Skip to main content

Table 4 Patient samples analyzed in this study

From: Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors

Patient Histology Age FIGO Stage Grade
228 Clear cell adenocarcinoma 55 Ia N/A
317 Serous papillary adenocarcinoma 59 Ic 3
170 Mixed endometrioid/serous papillary adenocarcinoma 57 IIa 2
413 Serous papillary adenocarcinoma 50 IIb 3
212 Mixed endometrioid/serous papillary adenocarcinoma 59 IIIc 3
369 Serous papillary adenocarcinoma 52 IIIc 3
242 Serous papillary adenocarcinoma 64 IIIc 3
229 Serous papillary adenocarcinoma 58 IIIc 3
183 Serous papillary adenocarcinoma 66 IIIc 2
412 Mucinous cystadenoma 65   
377 Mucinous cystadenoma 42   
383 Mucinous cystadenoma with focal borderline features 75   
382 Serous cystadenofibroma 67   
386 Serous cystadenofibroma 59   
388 Serous cystadenofibroma 53   
371 Serous cystadenofibroma 60   
400 Serous cystadenofibroma 43   
416 Serous cystadenoma 65   
492 Normal surface epithelium 38   
499 Normal surface epithelium 69   
500 Normal surface epithelium 25   
525 Normal surface epithelium 70